Improvements in pencil beam scanning proton therapy dose calculation accuracy in brain tumor cases with a commercial Monte Carlo algorithm.

Phys Med Biol. 2018 May 4 [Epub ahead of print]

Widesott L1Lorentini S2Fracchiolla F2Farace P2Schwarz M2.

1 Centro di Protonterapia, APSS , Via Al Desert 14, Trento, ITALY.

2 Centro di Protonterapia, APSS , Trento, ITALY

Abstract

validation of a commercial Monte Carlo (MC) algorithm (RayStation ver6.0.024) for the treatment of brain tumours with pencil beam scanning (PBS) proton therapy, comparing it via measurements and analytical calculations in clinically realistic scenarios. Methods: For the measurements a 2D ion chamber array detector (MatriXX PT)) was placed underneath the following targets: 1) anthropomorphic head phantom (with two different thickness) and 2) a biological sample (i.e. half lamb's head). In addition, we compared the MC dose engine vs. the RayStation pencil beam (PB) algorithm clinically implemented so far, in critical conditions such as superficial targets (i.e. in need of range shifter), different air gaps and gantry angles to simulate both orthogonal and tangential beam arrangements. For every plan the PB and MC dose calculation were compared to measurements using a gamma analysis metrics (3%, 3mm). Results: regarding the head phantom the gamma passing rate (GPR) was always >96% and on average > 99% for the MC algorithm; PB algorithm had a GPR ≤90% for all the delivery configurations with single slab (apart 95 % GPR from gantry 0° and small air gap) and in case of two slabs of the head phantom the GPR was >95% only in case of small air gaps for all the three (0°, 45°,and 70°) simulated beam gantry angles. Overall the PB algorithm tends to overestimate the dose to the target (up to 25%) and underestimate the dose to the organ at risk (up to 30%). We found similar results (but a bit worse for PB algorithm) for the two targets of the lamb's head where only two beam gantry angles were simulated. Conclusions: our results suggest that in PBS proton therapy range shifter (RS) need to be used with extreme caution when planning the treatment with an analytical algorithm due to potentially great discrepancies between the planned dose and the dose delivered to the patients, also in case of brain tumours where this issue could be underestimated. Our results also suggest that a MC evaluation of the dose has to be performed every time the RS is used and, mostly, when it is used with large air gaps and beam directions tangential to the patient surface. 13.

Richiedi informazioni per come accedere alle prestazioni del Centro di Protonterapia
Nome
Cognome
Il tuo indirizzo email
Telefono
La tua richiesta
Provincia autonoma di Trento, in conformità con l'art. 13 della Legge 196/2003 e successive modifiche, dichiara che i dati personali qui raccolti hanno finalità di registrare l'utente, attivare nei suoi confronti il servizio richiesto e fornirgli informazioni sull'attività ed i servizi del Centro di Protonterapia, nonché sulle iniziative e le attività promosse dallo stesso. Tali dati verranno trattati elettronicamente in conformità con le leggi vigenti; si garantisce la riservatezza degli stessi e che non saranno oggetto di comunicazione o diffusione a terzi. L'interessato può esercitare in qualsiasi momento i diritti di cui all'art. 7 della suddetta legge (accesso correzione e cancellazione dei dati), rivolgendosi a Provincia autonoma di Trento, uff.informazioni@provincia.tn.it.
CENTRO DI PROTONTERAPIA - TRENTO
INDIRIZZO:
Via Al Desert n.14, 38123 Trento

MAIL:
protonterapia@apss.tn.it

TELEFONO:
+39 0461 1953100

ORARI: Lun - Ven | 8.30 - 16.00